FDA NDC Directory · JSON-LD · Markdown

TRIESENCE

NDC 0078-0897 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION

Generic nametriamcinolone acetonide
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA022048
Dosage form / routeINJECTION, SUSPENSION · OPHTHALMIC
Active ingredientsTRIAMCINOLONE ACETONIDE (40 mg/mL)
Marketing started20241001
Package count1

External sources

Source: openFDA. Public-domain (CC0).